NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 914 filers reported holding NOVARTIS A G in Q4 2014. The put-call ratio across all filers is 0.42 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $55,705,000 | -1.5% | 764,761 | +6.8% | 0.06% | -7.2% |
Q3 2016 | $56,534,000 | +4.5% | 715,982 | +9.2% | 0.07% | +1.5% |
Q2 2016 | $54,116,000 | +28.8% | 655,868 | +13.1% | 0.07% | +23.6% |
Q1 2016 | $42,013,000 | +15.7% | 579,963 | +37.4% | 0.06% | +17.0% |
Q4 2015 | $36,323,000 | -15.0% | 422,159 | -9.1% | 0.05% | -19.0% |
Q3 2015 | $42,713,000 | -3.0% | 464,674 | +3.8% | 0.06% | +5.5% |
Q2 2015 | $44,015,000 | +11.7% | 447,580 | +12.0% | 0.06% | +5.8% |
Q1 2015 | $39,402,000 | +5.4% | 399,579 | -0.9% | 0.05% | +4.0% |
Q4 2014 | $37,376,000 | +6.8% | 403,370 | +8.5% | 0.05% | +2.0% |
Q3 2014 | $34,997,000 | +6.6% | 371,792 | +2.5% | 0.05% | +11.4% |
Q2 2014 | $32,828,000 | -1.3% | 362,615 | -7.3% | 0.04% | -8.3% |
Q1 2014 | $33,246,000 | +20.1% | 391,043 | +13.5% | 0.05% | +17.1% |
Q4 2013 | $27,691,000 | +8.5% | 344,504 | +3.6% | 0.04% | -2.4% |
Q3 2013 | $25,518,000 | +31.3% | 332,652 | +21.0% | 0.04% | +20.0% |
Q2 2013 | $19,438,000 | – | 274,892 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |